Meruvax, manufactured by Merck Sharp & Dohme, ca. 1970
Courtesy Smithsonian Institution National Museum of American History
Meruvax, the first commercially viable rubella vaccine, went into use in June 1969. It was based on the work of Drs. Paul Parkman (b. 1932) and Harry M. Meyer, Jr. (1928–2001) at the NIH.
